The goal is to identify the global prevalence of APOL1-Mediated Kidney Disease (AMKD) to better understand the impact of this rare disease and the needs of the APOL1-Mediated Kidney Disease (AMKD) community.
Have any questions? Please email us at admin@rare360.life.